pds5a Antibody

What is PDS5A and what cellular functions does it perform?

PDS5A is a nuclear protein belonging to the PDS5 protein family, with a canonical length of 1337 amino acid residues and a molecular weight of approximately 150.8 kDa in humans. It functions primarily as a regulator of sister chromatid cohesion during mitosis and stabilizes the association of the cohesin complex with chromatin . PDS5A is highly expressed in colon tissue and has up to two different isoforms reported .

The protein is also known by several synonyms including SCC-112, sister chromatid cohesion protein PDS5 homolog A, regulator of cohesion maintenance homolog A, cell proliferation-inducing gene 54 protein, and PIG54 . PDS5A plays crucial roles in:

• Regulating chromatin loop length and architectural stripes

• Promoting the formation of CTCF-anchored loops

• Contributing to DNA replication fork protection and restart

• Linking transcriptional silencing by Polycomb and 3D genome organization

What applications are PDS5A antibodies commonly used for?

PDS5A antibodies have been validated for multiple experimental applications:

These techniques enable researchers to examine PDS5A expression, localization, and interactions in various experimental contexts .

What factors should I consider when selecting a PDS5A antibody?

When selecting a PDS5A antibody, researchers should evaluate:

• Validated Applications: Ensure the antibody has been validated for your specific application (WB, IHC, IF, etc.) .

• Species Reactivity: Confirm reactivity with your experimental model organism (human, mouse, rat, etc.) .

• Epitope Region: Consider whether the antibody targets a specific domain (e.g., C-terminal) .

• Published Citations: Review literature where the antibody has been successfully used .

• Clonality: Polyclonal antibodies offer broader epitope recognition, while monoclonal antibodies provide higher specificity .

• Controls: Ensure appropriate controls are available, particularly for PDS5A-deficient cells/tissues .

The choice of antibody should be guided by your experimental design and the specific research questions being addressed.

What are the recommended dilutions and protocols for different applications of PDS5A antibodies?

Based on validated protocols, the following dilutions are recommended for PDS5A antibody applications:

For optimal results, titration of the antibody in your specific experimental system is strongly recommended . Positive controls have been validated in several cell lines, including HeLa, HEK-293, and Jurkat cells for Western blot applications, and A431 cells for immunofluorescence .

How do I troubleshoot non-specific binding or weak signals when using PDS5A antibodies?

When encountering issues with PDS5A antibody performance:

• For non-specific binding:

  • Increase blocking time/concentration

  • Optimize antibody dilution (try a more diluted solution)

  • Ensure proper washing steps between antibody incubations

  • Consider using different blocking agents (BSA, milk, serum)

  • Reduce primary antibody incubation time

• For weak signals:

  • Verify sample preparation and protein extraction methods

  • Confirm PDS5A expression in your cell type/tissue

  • Try antigen retrieval methods for IHC/IF (TE buffer pH 9.0 recommended)

  • Increase protein loading for Western blots

  • Extend primary antibody incubation time or concentration

• General considerations:

  • The observed molecular weight of PDS5A is approximately 130 kDa on SDS-PAGE, which differs slightly from the calculated 147 kDa

  • Storage conditions affect antibody performance (store at -20°C with glycerol)

How does PDS5A contribute to chromatin loop organization and what methodologies can assess these functions?

PDS5A plays a critical role in regulating chromatin loop length and architecture. Research has demonstrated that:

• PDS5A restricts the enlargement of chromatin loops genome-wide .

• PDS5A promotes the formation of CTCF-anchored loops .

• Cells lacking PDS5A show an increase in extended loops at the expense of primary loops .

To study these functions, researchers can employ:

• Hi-C or micro-C: To map genome-wide chromatin interactions and loop structures

• ChIP-seq: To identify PDS5A binding sites and co-localization with CTCF or cohesin

• CRISPR-Cas9 deletion: To generate PDS5A-deficient cells and assess loop alterations

• Difference plot analysis: To visualize changes in long-range interactions at CTCF sites

Importantly, PDS5A deletion results in an increase in the length of architectural stripes, with reduced enrichment near CTCF sites . This indicates that PDS5A not only promotes CTCF-anchored loops but also restricts loop enlargement throughout the genome.

What is the relationship between PDS5A and DNA replication/repair, and how can this be studied experimentally?

PDS5A plays significant roles in DNA replication and repair processes:

• PDS5A-deficient cells show signs of replication stress, with approximately 20% of cells in S and G2 phases displaying γH2AX staining .

• Cells lacking both PDS5A and PDS5B show increased sensitivity to ATR kinase inhibitors, indicating endogenous replication stress .

• PDS5A is required for proper recruitment of DNA repair factors like RAD51 and WRNIP1 to stalled replication forks .

Experimental approaches to study these functions include:

• Cell synchronization: Using nocodazole to synchronize cells in mitosis followed by release to study pre-RC assembly

• BrdU incorporation: To assess DNA replication efficiency

• Flow cytometry: To analyze cell cycle distribution in PDS5A-deficient cells

• Immunofluorescence: To visualize recruitment of repair factors like RAD51

• Chromatin fractionation: To biochemically assess protein association with chromatin upon hydroxyurea (HU) treatment

• Co-immunoprecipitation: To detect physical interactions between PDS5A, cohesin components, and repair factors

A key finding is that PDS5A interacts with WRNIP1, RAD51, and cohesin components in response to replication stress, suggesting it functions as part of a complex that protects stalled replication forks .

How does PDS5A loss affect gene expression, particularly Polycomb-regulated genes?

PDS5A deletion has significant impacts on gene expression, particularly affecting Polycomb target genes:

• Loss of PDS5A results in derepression of a subset of endogenous PRC1/PRC2 target genes .

• This derepression occurs without substantial loss of Polycomb chromatin domains .

• Instead, PDS5A removal causes aberrant cohesin activity leading to ectopic insulation sites that disrupt ultra-long Polycomb loops .

To study these effects, researchers have employed:

• CRISPR-Cas9 gene editing: To generate PDS5A knockout cell lines

• Gene-trap technology: For inducible loss-of-function studies

• RNA-seq: To identify differentially expressed genes upon PDS5A deletion

• RT-qPCR: To validate upregulation of specific PRC1/PRC2 target genes

• ChIP-seq: To assess changes in histone modifications associated with Polycomb activity

• Chromosome conformation capture: To analyze disruptions in long-range chromatin interactions

Gene Ontology analysis of upregulated genes in PDS5A-deficient cells reveals enrichment for developmental processes such as neurogenesis and pattern specification, consistent with derepression of Polycomb target genes .

How do the functions of PDS5A differ from its paralog PDS5B, and what experimental approaches can distinguish them?

PDS5A and PDS5B are paralogs with both overlapping and distinct functions:

• Functional redundancy: Both proteins regulate cohesin dynamics and contribute to sister chromatid cohesion .

• Distinct roles:

  • PDS5B has been shown to interact specifically with BRCA2 and RAD51 during DNA replication .

  • PDS5B can stimulate RAD51-mediated DNA strand invasion together with BRCA2 in vitro .

  • PDS5A appears more critical for regulating chromatin loop length .

Experimental approaches to distinguish their functions include:

• Single vs. double knockout studies: Comparing phenotypes of cells lacking PDS5A, PDS5B, or both .

• Growth rate analysis: PDS5A or PDS5B single knockout cells grow more slowly than wild-type cells, while doubly depleted cells grow very poorly .

• Protein-specific immunoprecipitation: To identify unique interaction partners .

• ChIP-seq: To map their distinct chromatin binding sites and co-localization patterns.

• Rescue experiments: Expressing one paralog in cells deficient for both to determine which functions can be rescued.

Importantly, simultaneous depletion of both PDS5A and PDS5B appears to be lethal, indicating their collective importance for cell viability .

What are the most effective experimental controls when studying PDS5A function using antibody-based approaches?

When investigating PDS5A function using antibody-based techniques, implement these controls:

• Negative controls:

  • PDS5A knockout or knockdown cells/tissues to validate antibody specificity

  • Isotype controls to account for non-specific binding

  • Secondary antibody-only controls to assess background

• Positive controls:

  • Cell lines with known PDS5A expression (HeLa, HEK-293, Jurkat cells)

  • Tissues with high PDS5A expression (colon)

  • PDS5A overexpression systems

• Validation strategies:

  • Multiple antibodies targeting different epitopes of PDS5A

  • Rescue experiments with PDS5A re-expression in knockout cells

  • Gene-trap systems allowing inducible PDS5A loss-of-function and restoration

• Technical considerations:

  • For Western blot, expect PDS5A to appear at approximately 130 kDa

  • For IHC/IF, validate staining pattern matches known nuclear localization

  • When studying protein interactions, include RNase/DNase treatments to distinguish DNA/RNA-mediated from direct protein-protein interactions

How should researchers interpret contradictory findings when studying PDS5A in different cellular contexts?

When encountering contradictory results across experimental systems:

• Consider cell type specificity:

  • PDS5A functions may vary between cell types based on expression levels of interaction partners

  • Embryonic stem cells may have different requirements for PDS5A compared to differentiated cells

  • Cancer cells often show altered cohesion dynamics that may affect PDS5A function

• Examine experimental conditions:

  • Cell cycle phase influences PDS5A activity and localization

  • Replication stress (e.g., hydroxyurea treatment) affects PDS5A interactions

  • Mitotic versus interphase cells may show different PDS5A dependencies

• Consider functional redundancy:

  • PDS5B may compensate for PDS5A loss in some contexts but not others

  • Other cohesin regulators might buffer the effects of PDS5A depletion

• Methodological differences:

  • Acute versus chronic depletion strategies may yield different phenotypes

  • Complete knockout versus partial knockdown may reveal different aspects of PDS5A function

  • Gene-trap versus CRISPR-based approaches might have different off-target effects

When publishing contradictory findings, researchers should carefully document experimental conditions and discuss potential context-dependent mechanisms for the observed differences.

What are the implications of PDS5A dysfunction for understanding human disease mechanisms?

PDS5A dysfunction has potential implications for several disease mechanisms:

• Cancer biology:

  • Altered chromosome cohesion and segregation can lead to aneuploidy, a hallmark of cancer

  • Disrupted chromatin loops may affect oncogene or tumor suppressor regulation

  • Impaired DNA replication and repair pathways increase genomic instability

• Developmental disorders:

  • Cohesinopathies are developmental disorders caused by mutations in cohesin components

  • PDS5A's role in Polycomb-mediated gene silencing suggests its dysfunction could disrupt developmental gene expression programs

  • Derepression of developmental genes could affect cell differentiation and tissue formation

• DNA repair deficiency syndromes:

  • PDS5A's involvement in replication fork protection suggests it may contribute to genome stability

  • Its interaction with RAD51 and WRNIP1 places it in DNA repair pathways relevant to cancer predisposition syndromes

Understanding PDS5A function may provide insights into diseases involving chromatin organization defects and inform therapeutic strategies targeting these pathways.